Ticker

No recent analyst price targets found for NTRBW.

Latest News for NTRBW

Nutriband CEO Publishes Letter to Shareholders

ORLANDO, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on achievements and milestones through 2025 and the potential outlook for 2026.

GlobeNewsWire • Dec 31, 2025
Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

Earthvision Bio, is currently developing and commercializing its line of sustainable products developed by Dr. Gordon Moore, the founder of Intel, and Dr. Hans Franke, ex-chairman for Chevron Europe Nutriband Inc. Shareholders will retain 10% of the shareholding in Earth Vision Bio following the acquisition The expected closing date for the transaction is Dec 31, 2025. ORLANDO, Fla.

GlobeNewsWire • Dec 29, 2025
Nutriband (NASDAQ:NTRBW) Trading 0.7% Higher – Should You Buy?

Nutriband Inc. (NASDAQ: NTRBW - Get Free Report) shares shot up 0.7% during mid-day trading on Friday. The stock traded as high as $1.52 and last traded at $1.52. 104 shares were traded during mid-day trading, a decline of 98% from the average session volume of 6,447 shares. The stock had previously closed at $1.51.

Defense World • Dec 27, 2025

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for NTRBW.

No House trades found for NTRBW.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top